These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6757800

  • 21. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N, Vaglini M, Rovini D, Orefice S, Marolda R, Veronesi U.
    Minerva Med; 1982 Apr 28; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract] [Full Text] [Related]

  • 22. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
    Zaumseil RP, Wohlrab W, Fiedler H, Wozniak KD.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Apr 28; 108(5):721-4. PubMed ID: 6172340
    [No Abstract] [Full Text] [Related]

  • 23. [Ureidosuccinate of 5(4)amino-4(5)imidazolecarboxamide: biopsy study after "controlled" use of the new substance in hepatic therapy].
    Cavazzuti F.
    Clin Ter; 1977 Nov 15; 83(3):243-77. PubMed ID: 603982
    [No Abstract] [Full Text] [Related]

  • 24. Letter: Treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed RC, Hersh EM.
    Lancet; 1974 Dec 14; 2(7894):1460. PubMed ID: 4140384
    [No Abstract] [Full Text] [Related]

  • 25. Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.
    Zielinski C, Pehamberger H, Endler AT, Knapp W.
    Clin Exp Immunol; 1979 Oct 14; 38(1):92-8. PubMed ID: 393441
    [Abstract] [Full Text] [Related]

  • 26. Letter: Treatment of malignant melanoma.
    Constanza ME, Nathanson L.
    Lancet; 1974 Dec 28; 2(7896):1565. PubMed ID: 4140995
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H, Muth M.
    Z Hautkr; 1982 Feb 15; 57(4):294-7. PubMed ID: 7080583
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T.
    Kekkaku; 1980 Aug 15; 55(8):359-63. PubMed ID: 6999203
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I, Kyselá T, Machálek J, Lochmanová A, Beska F.
    Cesk Dermatol; 1980 Aug 15; 55(6):372-7. PubMed ID: 7460040
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. DC therapy for metastatic melanoma.
    Ingram SB, O'Rourke MG.
    Cytotherapy; 2004 Aug 15; 6(2):148-53. PubMed ID: 15203991
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.